European Medical (ALEMS) | Stock Overview & Key Data
European Medical Solutions S.à r.l. | Small-cap | Healthcare
European Medical Solutions S.à r.l. | Small-cap | Healthcare
European Medical Performance Comparison
Stock Range
Today's Range
Low: €5.02
High: €5.03
on September 23, 2025
52 Week Range
Low: €4.20
High: €7.04
on September 15, 2025
on December 13, 2024
All-Time High: €2,956.45 on February 27, 2017
Explore how other BE stocks compare to their 52-week ranges: View BE Market 52-Week Insights
Key Statistics
Market Cap
€21.8M
EPS
0.13
P/E Ratio (TTM)
44.15
Forward P/E
N/A
P/B Ratio
2.35
PEG Ratio
N/A
Div. Yield
N/A
ROE
5.40%
Beta
0.482
Debt to Equity
191.98
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
3.24%
Profit Margin
1.14%
Returns and Earnings
Return on Assets (TTM)
1.70%
Return on Equity (TTM)
5.40%
EBITDA
€3.8M
Net Income (TTM)
€546.0K
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€11.32
Quarterly Revenue Growth (YoY)
19.20%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| European Medical ALEMS | 21.80M Small-cap | 22.62% | 9.57% | 9.57% | -16.94% | -14.17% | -24.60% | -87.28% | -92.81% |
| Argenx SE ARGX | 38.42B Large-cap | -1.07% | 11.60% | 35.45% | 11.72% | 3.34% | 31.86% | 71.29% | 177.33% |
| UCB S.A UCB | 39.10B Large-cap | 0.49% | 4.66% | 25.61% | 15.07% | 7.92% | 27.98% | 190.35% | 111.49% |
| Celyad Oncology S.A CYAD | 13.43M Small-cap | 3.33% | -22.50% | -22.50% | -46.55% | -53.73% | 14.81% | -79.19% | -96.23% |
| Biosenic SA BIOS | 1.57M Small-cap | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -80.00% | -98.25% | -99.73% |
| Onward Medical N.V ONWD | 245.24M Mid-cap | 1.54% | 4.35% | 20.55% | 10.92% | -1.12% | 3.13% | -0.38% | -58.56% |
Ownership & Short Interest
Insider Ownership
90.75%
Institutional Ownership
0.02%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
232
Average 90-Day Volume
123
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALEMS's 52-week high and low?
- In the last 52 weeks, European Medical reached a high of €7.04 (on December 13, 2024) and a low of €4.20 (on September 15, 2025).
- What is the market cap and P/E ratio for ALEMS?
- Curious about European Medical's size and valuation? Its market capitalization stands at 21.80M. When it comes to valuation, the P/E ratio (trailing twelve months) is 44.15, and the forward P/E (looking ahead) is N/A.
- Does ALEMS pay dividends? If so, what's the yield?
- As for dividends, European Medical isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are European Medical's main competitors or similar companies to consider before investing?
When looking at European Medical, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Argenx SE
ARGX38.42B Healthcare Biotechnology 31.86% 71.29% UCB S.A
UCB39.10B Healthcare Biotechnology 27.98% 190.35% Celyad Oncology S.A
CYAD13.43M Healthcare Biotechnology 14.81% -79.19% Biosenic SA
BIOS1.57M Healthcare Biotechnology -80.00% -98.25% Onward Medical N.V
ONWD245.24M Healthcare Biotechnology 3.13% -0.38% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for European Medical Solutions S.à r.l.? (e.g., ROE, Debt/Equity)
- To get a sense of European Medical's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 5.40%, the Debt to Equity ratio from the most recent quarter is 191.98, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALEMS?
- Looking at European Medical's growth, its revenue over the trailing twelve months (TTM) was €48M. Compared to the same quarter last year (YoY), quarterly revenue grew by 19.20%, and quarterly earnings saw a YoY growth of N/A.
- How much of ALEMS stock is held by insiders and institutions?
- Wondering who owns European Medical stock? Company insiders (like executives and directors) hold about 90.75% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.02%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.